Journal article 1678 views 3144 downloads
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Christopher Sorli,
Shin-ichi Harashima,
George M Tsoukas,
Jeffrey Unger,
Julie Derving Karsbøl,
Thomas Hansen,
Steve Bain 
The Lancet Diabetes & Endocrinology, Volume: 5, Issue: 4, Pages: 251 - 260
Swansea University Author:
Steve Bain
-
PDF | Accepted Manuscript
Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).
Download (866.67KB)
DOI (Published version): 10.1016/s2213-8587(17)30013-x
Abstract
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
| Published in: | The Lancet Diabetes & Endocrinology |
|---|---|
| ISSN: | 2213-8587 |
| Published: |
Elsevier BV
2017
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa31739 |
| first_indexed |
2017-01-25T14:56:58Z |
|---|---|
| last_indexed |
2020-07-31T18:48:34Z |
| id |
cronfa31739 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-07-31T14:43:35.4427937</datestamp><bib-version>v2</bib-version><id>31739</id><entry>2017-01-25</entry><title>Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-01-25</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>The Lancet Diabetes & Endocrinology</journal><volume>5</volume><journalNumber>4</journalNumber><paginationStart>251</paginationStart><paginationEnd>260</paginationEnd><publisher>Elsevier BV</publisher><issnPrint>2213-8587</issnPrint><keywords/><publishedDay>1</publishedDay><publishedMonth>4</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-04-01</publishedDate><doi>10.1016/s2213-8587(17)30013-x</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-07-31T14:43:35.4427937</lastEdited><Created>2017-01-25T09:18:36.6795613</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Christopher</firstname><surname>Sorli</surname><order>1</order></author><author><firstname>Shin-ichi</firstname><surname>Harashima</surname><order>2</order></author><author><firstname>George M</firstname><surname>Tsoukas</surname><order>3</order></author><author><firstname>Jeffrey</firstname><surname>Unger</surname><order>4</order></author><author><firstname>Julie Derving</firstname><surname>Karsbøl</surname><order>5</order></author><author><firstname>Thomas</firstname><surname>Hansen</surname><order>6</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>7</order></author></authors><documents><document><filename>0031739-25012017092302.pdf</filename><originalFilename>Sorli2017.pdf</originalFilename><uploaded>2017-01-25T09:23:02.6500000</uploaded><type>Output</type><contentLength>917546</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2017-07-17T00:00:00.0000000</embargoDate><documentNotes>Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
| spelling |
2020-07-31T14:43:35.4427937 v2 31739 2017-01-25 Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2017-01-25 MEDS Journal Article The Lancet Diabetes & Endocrinology 5 4 251 260 Elsevier BV 2213-8587 1 4 2017 2017-04-01 10.1016/s2213-8587(17)30013-x COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2020-07-31T14:43:35.4427937 2017-01-25T09:18:36.6795613 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Christopher Sorli 1 Shin-ichi Harashima 2 George M Tsoukas 3 Jeffrey Unger 4 Julie Derving Karsbøl 5 Thomas Hansen 6 Steve Bain 0000-0001-8519-4964 7 0031739-25012017092302.pdf Sorli2017.pdf 2017-01-25T09:23:02.6500000 Output 917546 application/pdf Accepted Manuscript true 2017-07-17T00:00:00.0000000 Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND). true eng |
| title |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial |
| spellingShingle |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial Steve Bain |
| title_short |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial |
| title_full |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial |
| title_fullStr |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial |
| title_full_unstemmed |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial |
| title_sort |
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial |
| author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
| author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
| author |
Steve Bain |
| author2 |
Christopher Sorli Shin-ichi Harashima George M Tsoukas Jeffrey Unger Julie Derving Karsbøl Thomas Hansen Steve Bain |
| format |
Journal article |
| container_title |
The Lancet Diabetes & Endocrinology |
| container_volume |
5 |
| container_issue |
4 |
| container_start_page |
251 |
| publishDate |
2017 |
| institution |
Swansea University |
| issn |
2213-8587 |
| doi_str_mv |
10.1016/s2213-8587(17)30013-x |
| publisher |
Elsevier BV |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
1 |
| active_str |
0 |
| published_date |
2017-04-01T07:01:08Z |
| _version_ |
1821297311516459008 |
| score |
11.04748 |